Literature DB >> 8430216

Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition.

O Kanno1, H Watanabe, H Kazamatsuri.   

Abstract

1. The effects of zopiclone 10mg (ZP), flunitrazepam 1mg (FN), triazolam 0.25mg (TZ) and levomepromazine 5mg (LP) on two models of sleep-wake schedule change-6 hours advanced shift: (A-shift), and 6 hours delayed: (D-shift)--were investigated in 6 healthy volunteers using polysomnography. 2. In A-shift with placebo, TST, SEI, %SR and REM/NREM decreased. ZP, FN and TZ shortened SL. All drugs increased TST and SEI. TZ and LP increased %SR and REM/NREM. 3. In D-shift with placebo, TST decreased, SWSL was prolonged, %S3+4 decreased, and %SR and REM/NREM increased. All drugs increased TST. ZP and LP shortened SWSL. All drugs increased %SWS. ZP, FN and TZ decreased %SR. ZP and FN decreased REM/NREM. 4. Daytime mental and physical conditions were worse than usual on more than half of the days in A- and D-shift. LP and FN caused some inadequate conditions on the following days. Significantly higher REM/NREM was observed in the nights before the days with worse mental conditions in D-shift, and lower REM/NREM in the nights before the days with worse physical conditions in A-shift. 5. It is concluded that TZ and ZP are superior to the others for A-shift and D-shift, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430216     DOI: 10.1016/0278-5846(93)90044-s

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  10 in total

Review 1.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

2.  A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Russell P Rosenberg; Steven G Hull; D Alan Lankford; David W Mayleben; David J Seiden; Sandy A Furey; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

3.  A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Sandy A Furey; Steven G Hull; Mark T Leibowitz; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

4.  Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement.

Authors:  Jaime Meléndez; Irina Galli; Katica Boric; Alonso Ortega; Leonardo Zuñiga; Carlos F Henríquez-Roldán; Ana M Cárdenas
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

Review 5.  Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.

Authors:  S Noble; H D Langtry; H M Lamb
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 6.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Effects of filtering visual short wavelengths during nocturnal shiftwork on sleep and performance.

Authors:  Shadab A Rahman; Colin M Shapiro; Flora Wang; Hailey Ainlay; Syeda Kazmi; Theodore J Brown; Robert F Casper
Journal:  Chronobiol Int       Date:  2013-07-08       Impact factor: 2.877

Review 8.  Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review.

Authors:  Laura Palagini; Carlotta Bianchini
Journal:  Front Neurosci       Date:  2022-07-29       Impact factor: 5.152

9.  Propofol versus flunitrazepam for inducing and maintaining sleep in postoperative ICU patients.

Authors:  Cornelius Engelmann; Jan Wallenborn; Derk Olthoff; Udo X Kaisers; Henrik Rüffert
Journal:  Indian J Crit Care Med       Date:  2014-04

10.  A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.

Authors:  Amy Bullock; Handan Gunduz-Bruce; Gary K Zammit; Min Qin; Haihong Li; Abdul J Sankoh; Christopher Silber; Stephen J Kanes; Jeffrey Jonas; James Doherty
Journal:  Hum Psychopharmacol       Date:  2021-08-05       Impact factor: 2.130

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.